
Opinion|Videos|November 22, 2024
MOA and Improved Outcomes: Gaps in Measuring Real-World Results
Key Takeaways
Sumit Sharma, MD, FASRS ponders to the panel the root cause of improved outcomes with newer agents. The panel then highlights current gaps in measuring visual improvements beyond tools such as the OCT, emphasizing the need for patient-centered treatment plans.
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Development of maculopathy associated with systemic medications
3
Throwback Series: The eye that found a cancer
4
Proactive strategies and sustained delivery advance glaucoma care
5


















































.png)


